{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T21:27:54Z","timestamp":1771709274683,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.bioorg.2019.102965","type":"journal-article","created":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T11:55:25Z","timestamp":1556798125000},"page":"102965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Design, synthesis and molecular modeling studies on novel moxifloxacin derivatives as potential antibacterial and antituberculosis agents"],"prefix":"10.1016","volume":"88","author":[{"given":"Asl\u0131","family":"T\u00fcre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Necla","family":"Kulaba\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serap \u0130pek","family":"Dingi\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaan","family":"Birg\u00fcl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arif","family":"Bozdeveci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015eeng\u00fcl","family":"Alpay Karao\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vagolu Siva","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dharmarajan","family":"Sriram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130lkay","family":"K\u00fc\u00e7\u00fckg\u00fczel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bioorg.2019.102965_b0005","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","article-title":"Antimicrobial resistance: a global multifaceted phenomenon","volume":"109","author":"Prestinaci","year":"2015","journal-title":"Pathog. Glob. Health."},{"issue":"4","key":"10.1016\/j.bioorg.2019.102965_b0010","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1128\/CMR.2.4.378","article-title":"Fluoroquinolone antimicrobial agents","volume":"2","author":"Wolfson","year":"1989","journal-title":"Clin. Microbiol. Rev."},{"issue":"S1","key":"10.1016\/j.bioorg.2019.102965_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg212","article-title":"Development of the quinolones","volume":"51","author":"Andersson","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bioorg.2019.102965_b0020","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1021\/cr030101q","article-title":"Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents","volume":"105","author":"Mitscher","year":"2005","journal-title":"Chem. Rev."},{"issue":"12","key":"10.1016\/j.bioorg.2019.102965_b0025","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1021\/jm501881c","article-title":"Origins of the quinolone class of antibacterials: an expanded \u201cDiscovery Story\u201d","volume":"58","author":"Bisacchi","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.102965_b0030","unstructured":"J. Crofton, P. Chaulet, D. Maher (contributions from J. Grosset, W. Harris, N. Horne, M. Iseman & B. Watt), Guidelines for the management of drug-resistant tuberculosis. Geneva: World Health Organization, 1997."},{"key":"10.1016\/j.bioorg.2019.102965_b0035","unstructured":"Global Tuberculosis Report. World Health Organization, Geneva, 2017."},{"key":"10.1016\/j.bioorg.2019.102965_b0040","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ejmech.2018.01.080","article-title":"Fluoroquinolone derivatives and their anti-tubercular activities","volume":"146","author":"Fan","year":"2018","journal-title":"Eur. J. Med Chem."},{"issue":"E12","key":"10.1016\/j.bioorg.2019.102965_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/emi.2016.12","article-title":"Moxifloxacin and gatifloxacin for initial therapy of tuberculosis: a meta-analysis of randomized clinical trials","volume":"5","author":"Ruan","year":"2016","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.bioorg.2019.102965_b0050","unstructured":"http:\/\/www.clinicaltrials.gov\/ct2\/results?cond=Tuberculosis&term=moxifloxacin&cntry=&state=&city=&dist= (data accessed on April 19th, 2019)."},{"key":"10.1016\/j.bioorg.2019.102965_b0055","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00253-011-3557-z","article-title":"Exploiting bacterial DNA gyrase as a drug target: current state and perspectives","volume":"92","author":"Collin","year":"2011","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.bioorg.2019.102965_b0060","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.biopha.2018.04.021","article-title":"DNA gyrase inhibitors: progress and synthesis of potent compounds as antibacterial agents","volume":"103","author":"Khan","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.bioorg.2019.102965_b0065","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1073\/pnas.1525047113","article-title":"Crystal structure and stability of gyrase-fluoroquinolone cleaved complexes from Mycobacterium tuberculosis","volume":"113","author":"Blower","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.bioorg.2019.102965_b0070","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.drudis.2016.11.006","article-title":"DNA topoisomerase I and DNA gyrase as targets for TB therapy","volume":"22","author":"Nagaraja","year":"2017","journal-title":"Drug Discov. Today."},{"key":"10.1016\/j.bioorg.2019.102965_b0075","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.1016\/j.bmc.2009.06.053","article-title":"7-((4-Substituted)piperazin-1-yl) derivatives of ciprofloxacin: synthesis and in vitro biological evaluation as potential antitumor agents","volume":"17","author":"Azema","year":"2009","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2019.102965_b0080","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2174\/157340609789117859","article-title":"Antibacterial activity of lipophilic fluoroquinolone derivatives","volume":"5","author":"de Almeida","year":"2009","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2019.102965_b0085","doi-asserted-by":"crossref","unstructured":"M. Abdel-Aziz, S.E. Park, D. Abuo-Rahma Gel, M.A. Sayed, Y. Kwon, Novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids: synthesis, physicochemical properties, anticancer and topoisomerase I and II inhibitory activity, Eur. J. Med. Chem. 69 (2013) 427\u2013438.","DOI":"10.1016\/j.ejmech.2013.08.040"},{"key":"10.1016\/j.bioorg.2019.102965_b0090","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1021\/jm040204g","article-title":"Synthesis and antibacterial activity of the 4-quinolone-3-carboxylic acidderivatives having a trifluoromethyl group as a novel N-1 substituent","volume":"48","author":"Asahina","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.102965_b0095","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1016\/j.bmc.2005.05.063","article-title":"Synthesis and antimycobacterial evaluation of various 7-substituted ciprofloxacin derivatives","volume":"13","author":"Sriram","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.102965_b0100","doi-asserted-by":"crossref","unstructured":"A. Foroumadi, S. Ghodsi, S. Emami, S, Najjari, N, Samadi, M.A. Faramarzi, L. Beikmohammadi, F.H. Shirazi, A. Shafiee, Synthesis and antibacterial activity of new fluoroquinolonescontaining a substituted N-(phenethyl)piperazine moiety, Bioorg. Med. Chem. Lett. 16 (2006) 3499\u20133503.","DOI":"10.1016\/j.bmcl.2006.03.103"},{"key":"10.1016\/j.bioorg.2019.102965_b0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.biopha.2007.10.004","article-title":"Antimycobacterial activities of novel fluoroquinolones","volume":"63","author":"Senthilkumar","year":"2009","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.bioorg.2019.102965_b0110","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.bmcl.2009.01.007","article-title":"Synthesis of citrate-ciprofloxacin conjugates","volume":"19","author":"Md-Saleh","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.102965_b0115","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jfluchem.2011.02.002","article-title":"Synthesis of N-aryl-2,2,2-trifluoroacetimidoyl piperazinylquinolone derivatives and their antibacterial evaluations","volume":"132","author":"Darehkordi","year":"2011","journal-title":"J. Fluorine Chem."},{"key":"10.1016\/j.bioorg.2019.102965_b0120","doi-asserted-by":"crossref","first-page":"5961","DOI":"10.1016\/j.bmcl.2011.07.060","article-title":"Preparation and antibacterial evaluation of decarboxylated fluoroquinolones","volume":"21","author":"Nguyen","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.102965_b0125","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejmech.2012.11.040","article-title":"Synthesis and in vitro activity of 1,2,4-triazole-ciprofloxacin hybrids against drug-susceptible and drug-resistant bacteria","volume":"60","author":"Plech","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"20","key":"10.1016\/j.bioorg.2019.102965_b0130","doi-asserted-by":"crossref","first-page":"6513","DOI":"10.1016\/j.bmcl.2012.05.026","article-title":"Studies on the antimicrobial properties of N-acylated ciprofloxacins","volume":"22","author":"Cormier","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.102965_b0135","doi-asserted-by":"crossref","first-page":"7557","DOI":"10.3390\/molecules18077557","article-title":"New 7-[4-(4-(un)substituted)piperazine-1-carbonyl]-piperazin-1-yl] derivatives of fluoroquinolone: synthesis and antimicrobial evaluation","volume":"18","author":"Chen","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2019.102965_b0140","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1007\/s11095-013-1250-x","article-title":"Pharmacological characterization of 7-(4-(piperazin-1-yl)) ciprofloxacin derivatives: antibacterial activity, cellular accumulation, susceptibility to efflux transporters, and intracellular activity","volume":"31","author":"Marquez","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bioorg.2019.102965_b0145","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1021\/acsmedchemlett.5b00146","article-title":"Syntheses and antibacterial activity of N-acylated ciprofloxacin derivatives based on the trimethyl lock","volume":"6","author":"Ji","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.102965_b0150","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.arabjc.2011.04.008","article-title":"Synthesis and antibacterial evaluation of novel analogs of fluoroquinolones annulated with 6-substituted-2-aminobenzothiazoles","volume":"8","author":"Sharma","year":"2015","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.bioorg.2019.102965_b0155","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ejmech.2016.06.054","article-title":"Synthesis and biological evaluation of 6-fluoro-3-phenyl-7- piperazinyl quinolone derivatives as potential topoisomerase I inhibitors","volume":"122","author":"Ge","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.102965_b0160","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejmech.2016.03.086","article-title":"Synthesis and biological evaluation of novel structural hybrids of benzofuroxan derivatives and fluoroquinolones","volume":"116","author":"Chugunova","year":"2016","journal-title":"Eur. J. Med. Chem"},{"key":"10.1016\/j.bioorg.2019.102965_b0165","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.bmcl.2016.03.062","article-title":"Synthesis and molecular modeling of antimicrobial active fluoroquinolone\u2013pyrazine conjugates with amino acid linkers","volume":"26","author":"Panda","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.102965_b0170","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ejmech.2016.08.031","article-title":"Design, synthesis and biological evaluation of ciprofloxacin tethered bis-1,2,3-triazole conjugates as potent antibacterial agents","volume":"124","author":"Kant","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.102965_b0175","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.bmcl.2017.01.073","article-title":"New 1,4-dihydro[1,8]naphthyridine derivatives as DNA gyrase inhibitors","volume":"27","author":"Gen\u00e7er","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.102965_b0180","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.ejmech.2017.11.090","article-title":"Synthesis and in vitro evaluation of novel substituted isatinpropylene-1H-1,2,3-triazole-4-methylene-moxifloxacin hybrids for their anti-mycobacterial activities","volume":"143","author":"Yan","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.102965_b0185","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.molstruc.2018.02.116","article-title":"Chemical and biological evaluation of moxifloxacin-benzimidazole mixed ligands complexes: anti-cancer and anti-oxidant activities","volume":"1163","author":"Refaat","year":"2018","journal-title":"J. Mol. Str."},{"key":"10.1016\/j.bioorg.2019.102965_b0190","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ejmech.2018.01.078","article-title":"Ciprofloxacin derivatives and their antibacterial activities","volume":"146","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.102965_b0195","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.bmcl.2018.03.085","article-title":"Design, synthesis, and evaluation of novel N-1 fluoroquinolone derivatives: probing for binding contact with the active site tyrosine of gyrase","volume":"10","author":"Towle","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.102965_b0200","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11030-017-9795-y","article-title":"Synthesis of novel tetrazole containing hybrid ciprofloxacin and pipemidic acid analogues and preliminary biological evaluation of their antibacterial and antiproliferative activity","volume":"22","author":"Dileep","year":"2018","journal-title":"Mol. Divers."},{"issue":"46","key":"10.1016\/j.bioorg.2019.102965_b0205","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.1016\/j.ejmech.2011.09.011","article-title":"Design, synthesis and antibacterial activity of fluoroquinolones containing bulky arenesulfonyl fragment: 2D-QSAR and docking study","volume":"46","author":"Abdel-Aziz","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.102965_b0210","first-page":"839","article-title":"Synthesis and evaluation of novel 1,3,4-thiadiazole{fluoroquinolone hybrids as antibacterial, antituberculosis, and anticancer agents","volume":"42","author":"Demirci","year":"2018","journal-title":"Turk. J. Chem."},{"issue":"Suppl 2","key":"10.1016\/j.bioorg.2019.102965_b0215","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/cid\/civ072","article-title":"Lactobacillus species: taxonomic complexity and controversial susceptibilities","volume":"60","author":"Goldstein","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.bioorg.2019.102965_b0220","first-page":"4363","article-title":"Synthesis of various sulphonamide-linked fluoroquinolones as antibacterial agents","volume":"22","author":"Deepika","year":"2010","journal-title":"Asian J. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2019.102965_b0225","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1016\/j.bmcl.2016.10.082","article-title":"Design, development of new synthetic methodology, and biological evaluation of substituted quinolines as new anti-tubercular leads","volume":"26","author":"Tanwar","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.102965_b0230","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/minf.201400120","article-title":"Design of novel mycobacterium tuberculosis pantothenate synthetase inhibitors: virtual screening, synthesis and in vitro biological activities","volume":"34","author":"Devi","year":"2015","journal-title":"Mol. Inf."},{"key":"10.1016\/j.bioorg.2019.102965_b0235","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.bmc.2017.12.044","article-title":"Synthesis and evaluation of 40,50-dihydrospiro[piperidine-4,70-thieno[2,3-c]pyran] analogues against both active and dormant Mycobacterium tuberculosis","volume":"26","author":"Alluri","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.102965_b0240","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/minf.201400058","article-title":"Discovery of novel mycobacterial GNA gyrase B inhibitors: in silico and in vitro biological evaluation","volume":"33","author":"Saxena","year":"2014","journal-title":"Mol. Inf."},{"key":"10.1016\/j.bioorg.2019.102965_b0245","unstructured":"G.L. Woods, B.A. Brown-Elliott, E.P. Desmond, G.S. Hall, L. Heifets, G.E. Pfyffer, J.C. Ridderhof, R.J. Wallace Jr., N.C. Warren, F.G. Witebsky, Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; Approved Standard. NCCLS document M24-A 23 (18) (2003)."},{"key":"10.1016\/j.bioorg.2019.102965_b0250","unstructured":"P. A. Willanova, Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline. NCCLS document M26-A 19 (18) (1999)."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818312999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818312999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:50:50Z","timestamp":1758613850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206818312999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":50,"alternative-id":["S0045206818312999"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.102965","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and molecular modeling studies on novel moxifloxacin derivatives as potential antibacterial and antituberculosis agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.102965","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102965"}}